Saturday 17 October 2026
Export MNTK’s income statement to Excel — free account
Montauk Renewables, Inc.
MNTK Basic Materials Specialty Chemicals
Montauk Renewables, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.4 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 19.7%, EPS grew 104.0%, free cash flow grew 60.4% and total debt rose 114.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.14
0.02
+0.94%
Follow MNTK
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 4 | 7 | 5 | — | — | — |
P/E ratio |
100.00 | 61.23 | 83.29 | 41.97 | 0.00 | 293.25 | 293.25 | 293.25 |
Altman Z-Score |
1.44 | 4.67 | 8.69 | 10.42 | 9.07 | — | — | — |
P/S ratio |
1.35 | 3.22 | 7.23 | 7.27 | 9.76 | 16.61 | 16.61 | 16.61 |
Altman Z″-Score (non-manufacturers) |
2.10 | 4.22 | 4.64 | 5.37 | 3.02 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 24.96 | 43.85 | 151.07 | 151.07 | 151.07 |
Beneish M-Score |
(2.76) | (3.30) | (2.85) | (3.04) | (1.76) | (3.33) | — | — |
P/Operating CF |
708.74 | 782.14 | 58.89 | 70.30 | 66.98 | 275.71 | 275.71 | 275.71 |
P/B ratio |
0.91 | 2.20 | 5.05 | 6.58 | 7.93 | 10.45 | 10.45 | 10.45 |
Price to Tangible BV |
0.98 | 2.37 | 5.45 | 7.07 | 8.59 | 11.50 | 11.50 | 11.50 |
EV/Sales |
1.95 | 3.28 | 7.17 | 7.11 | 9.93 | 17.06 | 17.06 | 17.06 |
EV/EBITDA |
11.01 | 14.41 | 27.76 | 22.24 | 55.13 | 64.88 | 64.88 | 64.88 |
EV/Operating CF |
11.33 | 13.16 | 30.54 | 18.02 | 34.31 | 59.69 | 59.69 | 59.69 |
EV/FCF |
(3.99) | (32.88) | (56.90) | 24.39 | 44.63 | 155.13 | 155.13 | 155.13 |
Quick Ratio |
1.01 | 1.61 | 2.95 | 4.28 | 2.91 | 0.93 | 0.87 | 2.05 |
Current Ratio |
1.11 | 1.71 | 3.07 | 4.40 | 3.06 | 1.14 | 0.99 | 2.10 |
Net Debt/EBITDA |
3.36 | 0.25 | (0.23) | (0.51) | 0.97 | 1.70 | 1.78 | 0.74 |
Debt/Assets |
29.56% | 15.95% | 18.13% | 21.49% | 27.65% | 25.96% | 27.32% | 0.00% |
Debt/Equity |
0.49 | 0.22 | 0.25 | 0.31 | 0.43 | 0.41 | 0.43 | 0.00 |
Asset Turnover |
0.45 | 0.50 | 0.51 | 0.66 | 0.55 | 0.40 | 0.87 | 0.44 |
Operating CF/Net income |
17.35 | 4.50 | 2.75 | 2.30 | (9.47) | 6.23 | 4.78 | 1.73 |
Capex/Depreciation |
(3.84) | (2.57) | (2.93) | (1.00) | (0.42) | (0.77) | (2.18) | (2.31) |
Interest Coverage |
0.18 | 3.06 | 4.11 | 24.87 | 1.14 | 0.83 | 1.97 | 11.62 |
| 0.67% | 3.83% | 6.26% | 17.19% | (2.65%) | 2.93% | 3.85% | 19.04% | |
| 0.45% | 2.78% | 4.38% | 11.37% | (1.68%) | 1.85% | 4.78% | 10.88% | |
ROIC |
0.14% | 3.77% | 6.16% | 14.41% | 1.00% | 1.10% | 3.26% | 57.51% |
Return on Tangible Assets |
0.51% | 3.53% | 5.43% | 12.92% | (1.96%) | 2.42% | 3.01% | 14.16% |
Average Days of Receivables |
20.42 | 17.06 | 26.61 | 28.80 | 45.04 | 19.81 | 34.42 | 34.96 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
62.01% | 58.58% | 53.84% | 44.47% | 62.13% | 59.83% | 50.53% | 35.65% |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 | 0.00 |
Share Based Compensation of Revenue |
2.52% | 5.67% | 4.76% | 4.79% | 15.13% | 0.76% | 0.54% | 0.55% |
Graham Net Nets |
(0.57) | (0.06) | (0.01) | 0.01 | (0.02) | (0.04) | (0.04) | (0.04) |
Graham Number |
0.83 | 1.63 | 2.06 | 3.02 | 0.00 | 1.01 | 0.00 | 0.00 |
Earnings Yield |
1.00% | 1.63% | 1.20% | 2.38% | (0.29%) | 0.34% | 0.34% | 0.34% |
Free Cash Flow Yield |
(36.09%) | (3.10%) | (1.74%) | 4.01% | 2.28% | 0.66% | 0.66% | 0.66% |
Revenue per Share |
1.23 | 1.24 | 1.23 | 1.46 | 1.05 | 0.71 | 0.74 | 0.82 |
Operating CF per Share |
0.21 | 0.31 | 0.29 | 0.57 | 0.30 | 0.20 | 0.20 | 0.35 |
Capex per Share |
(0.81) | (0.43) | (0.45) | (0.15) | (0.07) | (0.12) | (0.32) | (0.28) |
Free Cash Flow per Share |
(0.60) | (0.12) | (0.16) | 0.42 | 0.23 | 0.08 | (0.13) | 0.08 |
Cash per Share |
0.17 | 0.32 | 0.52 | 0.74 | 0.38 | 0.15 | 0.07 | 0.38 |
Shareholders Equity per Share |
1.84 | 1.81 | 1.77 | 1.61 | 1.29 | 1.12 | 1.09 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.84 | 1.81 | 1.77 | 1.61 | 1.29 | 1.12 | 1.09 | 0.00 |
Free Cash Flow |
(86.21) | (17.53) | (22.04) | 59.88 | 32.97 | 11.04 | (17.78) | 10.74 |
Working Capital |
3.73 | 23.70 | 60.83 | 96.47 | 50.61 | 4.02 | (0.15) | 34.79 |
Capital Expenditures |
(116.54) | (61.32) | (63.09) | (21.19) | (9.91) | (17.65) | (45.61) | (38.91) |
Net Current Asset Value |
(135.16) | (34.37) | (9.82) | 19.64 | (29.02) | (61.25) | (66.81) | 66.49 |
EV/EBIT |
403.55 | 35.74 | 53.04 | 32.77 | 441.18 | 478.16 | 478.16 | 478.16 |
Capex to Sales |
0.66 | 0.35 | 0.36 | 0.10 | 0.07 | 0.18 | 0.43 | 0.34 |
Price to Operating Income |
280.33 | 35.12 | 53.48 | 33.53 | 433.41 | 465.66 | 465.66 | 465.66 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.09 | 0.09 | 0.10 | 0.12 | 0.13 | 0.12 | 0.11 | 0.10 |
Cash ROIC |
(20.74%) | (4.89%) | (5.69%) | 14.83% | 10.47% | 4.48% | (7.71%) | 7.31% |
Accounts Receivable Turnover |
19.51 | 16.76 | 12.07 | 11.92 | 12.49 | 13.02 | 10.07 | 10.97 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
9.04 | 10.48 | 14.49 | 17.25 | 11.86 | 7.71 | 10.50 | 10.50 |
Average Payables |
12.25 | 8.39 | 6.24 | 4.77 | 5.47 | 4.90 | 4.19 | 4.19 |
Average Assets |
392.24 | 349.63 | 341.28 | 309.40 | 269.92 | 248.48 | 121.81 | 264.51 |
Average Common Equity |
260.28 | 253.83 | 238.67 | 204.69 | 170.96 | 156.94 | 151.10 | 151.10 |
Columns are period end dates